Escalon Medical Basic EPS 2010-2024 | ESMC
Escalon Medical basic eps from 2010 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
Escalon Medical Annual Basic EPS |
2024 |
$-0.02 |
2023 |
$0.03 |
2022 |
$0.00 |
2021 |
$-0.01 |
2020 |
$-0.09 |
2019 |
$-0.04 |
2018 |
$0.07 |
2017 |
$-0.10 |
2016 |
$-0.15 |
2015 |
$-0.07 |
2014 |
$-0.05 |
2013 |
$0.35 |
2012 |
$-0.79 |
2011 |
$-0.77 |
2010 |
$-0.06 |
2009 |
$-1.81 |
Escalon Medical Quarterly Basic EPS |
2024-12-31 |
$0.02 |
2024-09-30 |
$-0.01 |
2024-06-30 |
$0.02 |
2024-03-31 |
$-0.02 |
2023-12-31 |
$-0.01 |
2023-09-30 |
$-0.01 |
2023-06-30 |
$0.00 |
2023-03-31 |
$0.08 |
2022-12-31 |
$0.00 |
2022-09-30 |
$-0.05 |
2022-06-30 |
$0.01 |
2022-03-31 |
$-0.04 |
2021-12-31 |
$-0.01 |
2021-09-30 |
$0.04 |
2021-06-30 |
$0.03 |
2021-03-31 |
$-0.02 |
2020-12-31 |
$0.01 |
2020-09-30 |
$-0.03 |
2020-06-30 |
$-0.06 |
2020-03-31 |
$-0.02 |
2019-12-31 |
$-0.09 |
2019-09-30 |
$0.08 |
2019-06-30 |
|
2019-03-31 |
$0.00 |
2018-12-31 |
$-0.03 |
2018-09-30 |
$-0.01 |
2018-06-30 |
$0.01 |
2018-03-31 |
$-0.02 |
2017-12-31 |
$0.09 |
2017-09-30 |
$-0.01 |
2017-06-30 |
$-0.03 |
2017-03-31 |
$-0.01 |
2016-12-31 |
$-0.01 |
2016-09-30 |
$-0.05 |
2016-06-30 |
$-0.06 |
2016-03-31 |
$-0.01 |
2015-12-31 |
$-0.04 |
2015-09-30 |
$-0.04 |
2015-06-30 |
$-0.01 |
2015-03-31 |
$0.01 |
2014-12-31 |
$-0.01 |
2014-09-30 |
$-0.06 |
2014-06-30 |
$-0.05 |
2014-03-31 |
$0.01 |
2013-12-31 |
$-0.01 |
2013-09-30 |
$0.00 |
2013-06-30 |
$-0.08 |
2013-03-31 |
$-0.04 |
2012-12-31 |
$0.53 |
2012-09-30 |
$-0.06 |
2012-06-30 |
$-0.13 |
2012-03-31 |
$-0.09 |
2011-12-31 |
$-0.47 |
2011-09-30 |
$-0.10 |
2011-06-30 |
$-0.28 |
2011-03-31 |
$-0.26 |
2010-12-31 |
$-0.14 |
2010-09-30 |
$-0.09 |
2010-06-30 |
$0.21 |
2010-03-31 |
$-0.04 |
2009-12-31 |
$-0.14 |
2009-09-30 |
$-0.09 |
2009-06-30 |
$-1.55 |
2009-03-31 |
$-0.09 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$0.001B |
$0.012B |
Escalon Medical Corp. develops, markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. The company utilizes strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the company's distribution capabilities.
|